Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Tonogenchoncel-L (Invossa) Gene Therapy for Regeneration of Cartilage in Patients with Degenerative Arthritis or Osteoarthritis of the Knee	Tonogenchoncel-L (Invossa; TG-C)	Regeneration of cartilage	Musculoskeletal System	2017	View \| Download
Tolebrutinib for treating relapsing multiple sclerosis	Tolebrutinib (PRN-2246;SAR-442168)	Multiple sclerosis (MS)	Neurology	2023	View \| Download
Tolebrutinib for treating relapsing and progressive forms of multiple sclerosis	Tolebrutinib (PRN-2246;SAR-442168)	Multiple sclerosis (MS)	Neurology	2023	View \| Download
Tofersen for the treatment of amyotrophic lateral sclerosis caused by mutations in the SOD1 gene	Tofersen sodium (BIIB067)	Motor neurone disease (MND or ALS)	Neurology	2020	View \| Download
Tofacitinib for polyarticular juvenile idiopathic arthritis	Tofacitinib citrate (Xeljanz; CP-690550)	Juvenile idiopathic arthritis	Rheumatology	2019	View \| Download
Tofacitinib for Ankylosing Spondylitis	Tofacitinib citrate (Xeljanz; CP-690550)	Ankylosing spondylitis	Musculoskeletal System	2020	View \| Download
Tocilizumab biosimilar for treating moderate to severe active rheumatoid arthritis	Tocilizumab biosimilar (Avtozma)	Rheumatoid arthritis	Rheumatology	2023	View \| Download
Tocilizumab (RoActemra) for Adults with Systemic Sclerosis – Second Line	Tocilizumab (Actemra; R1569; RoActemra)	Systemic sclerosis	Dermatology , Respiratory System	2017	View \| Download
Tocilizumab (RoActemra) for Adults with Giant Cell Arteritis - intravenous injection	Tocilizumab (Actemra; R1569; RoActemra)	Giant cell arteritis	Cardiovascular System	2018	View \| Download
Tocilizumab (RoACTEMRA) [subcutaneous injection with an auto injector device] for adult patients with moderate to severe active rheumatoid arthritis - after DMARD failure	Tocilizumab (Actemra; R1569; RoActemra)	Rheumatoid arthritis	Rheumatology	2017	View \| Download